Aimcare

We’re excited to share that we’ve been selected as part of the second cohort of the Investing in Innovation (i3 program).

It's an incredible opportunity to be chosen among the top 29 startups across Africa. We're grateful to the i3 selection committees, Bill & Melinda Gates Foundation, Cencora (formerly AmerisourceBergen), Merck Sharp & Dohme (MSD), Microsoft and Chemonics for believing in our mission.

Our team looks forward to receiving access to market opportunities to foster growth-focused partnerships, investment readiness support, and a $50,000 grant to help us grow and make a meaningful impact.

We can't wait to participate in the Access to Market event in Nairobi this November 💥.

The Sub-Saharan African market is a growing market that you should pay attention to as a healthcare organisation looking to expand into new territories.

We can help you. Come talk to us.

Email: [email protected]

We want you on our team!

Come join us.

Follow the link for more information: https://docs.google.com/document/d/1X255vBcTU0kcsdGpLYzVEVT5kLNjc5_MfCYpru-X0AA/edit?usp=sharing